Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events

Vaccine

Volumn 13, Issue 8, 1995, Pages 759-762

  Hedenström, Michael v ^a   Heberle, Uwe ^b   Theobald, Klaus ^a  

^a Behringwerke AG   (Germany)

^b Biometric Department ^*  (Germany)

Author keywords

clinical trial; ELISA; immunization; immunoglobulin; Tick borne encephalitis; vaccine

Indexed keywords

IMMUNOGLOBULIN; TICK BORNE ENCEPHALITIS VACCINE;

ADULT; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLUENZA; INJECTION PAIN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEROCONVERSION; TICK BORNE ENCEPHALITIS; VACCINATION;

ADULT; ANTIBODIES, VIRAL; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; MALE; PROSPECTIVE STUDIES; VACCINATION; VIRAL VACCINES;

EID: 0029085140     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(94)00032-I     Document Type: Article

References (16)

1. Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine
2. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens
3. A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study
4. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization
5. Frühsommer-Meningoenzephalitis (FSME) in Europa
6. Die Frühsommer-Meningoenzephalitis
7. Antibody-dependent enhancement of tick-borne encephalitis virus infectivity
8. Zur Wirksamkeit von FSME-Immunglobulin
9. WHO Expert Committee on Rabies
10. Passive-active immunization against hepatitis B
11. Tetanus Surveillance and Prophylaxis
12. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment
13. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine
14. A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies
15. Der Kinderarzt